Exclusive financial advisor to Hitachi High-Tech Corporation

KPMG Corporate Finance LLC acted as exclusive financial advisor to Hitachi High-Tech Corporation

KPMG Corporate Finance LLC and KPMG FAS Co., Ltd. acted as exclusive investment banking advisor to Hitachi High-Tech Corporation (Hitachi High-Tech or HHT) on its strategic investment in Invivoscribe, Inc. (IVS), a global provider of blood cancer testing kits and services. In addition to cross-border investment banking advisory services, KPMG LLP also provided financial due diligence and tax due diligence services thereby providing a fully integrated and multidisciplinary solution for HHT.

"Invivoscribe is excited by the synergistic opportunities, combining our core expertise in global standardization of tests and bioinformatics, our clinical lab services, and our processes for developing custom companion diagnostics from analytical/clinical validations through international regulatory approvals and commercialization, with Hitachi’s expertise in instrumentation development and manufacturing,” said Jeffrey Miller, CEO and founder of Invivoscribe.

About Hitachi High-Tech

Hitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including the manufacture and sales of clinical analyzers, biotechnology products, analytical instruments, semiconductor manufacturing equipment, and analysis equipment, and providing high value-added solutions in the fields of social and industrial infrastructures and mobility. HHT’s consolidated revenues for FY 2021 were approximately USD 5.1 billion.

About Invivoscribe

Invivoscribe has been improving lives with Precision Diagnostics for more than twenty-five years, advancing the field of precision medicine by developing and selling standardized reagents, tests, and bioinformatics tools to more than 700 customers in 160 countries. Invivoscribe is engaged in three core business functions: 1) testing services for blood cancers, 2) global sales and distribution of test kits and licensing bioinformatics software, and 3) the development and commercialization of companion diagnostics to support pharmaceutical approval of new oncology treatments.

KPMG Corporate Finance

The global Corporate Finance practice of KPMG International’s network of independent member firms was ranked as the top (#1) M&A middle-market adviser globally by Refinitiv, based on number of completed transactions, for the past 20 years.

Trust KPMG Corporate Finance LLC with your next transaction.

Jason Moran

Jason Moran

Managing Director, KPMG Corporate Finance LLC

+1 415-963-7353


 
 
Corporate finance services, including Financing, Debt Advisory, and Valuation Services, are not performed by all KPMG member firms and are not offered by member firms in certain jurisdictions due to legal or regulatory constraints. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act upon such information without appropriate professional advice after a thorough examination of the particular situation. 
 
The information contained in this communication may not be representative of the experience of other clients and does not constitute a recommendation, offer, or solicitation to buy, sell or hold any security of any issuer. Past performance does not guarantee future results.
 
©2022 KPMG Corporate Finance LLC, a Delaware limited liability company. Member FINRA/SIPC. KPMG Corporate Finance LLC is a subsidiary of KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Corporate Finance LLC is not engaged in the practice of public accountancy. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.